pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,939 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07470905: Development and Preclinical Validation of DiaBuddy, a Point-of-Care Decision Support Tool for Children With Type 1 Diabetes: A Pilot Clinical Study

    Sponsor: Regency Hospital Kanpur. Phase: NA. Conditions: Type 1 Diabetes (T1D)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

    Sponsor: Target PharmaSolutions, Inc.. Phase: . Conditions: Hepatocellular Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06189066: Long COVID Ultrasound Trial

    Sponsor: SecondWave Systems Inc.. Phase: NA. Conditions: Long Covid

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07137429: Platelet Volunteers, Longitudinal and Multi-omic Study

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Thrombosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07091929: A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

    Sponsor: Beijing Sungen Biomedical Technology Co., Ltd. Phase: PHASE1. Conditions: Anterior Myocardial Infarction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06850831: Effect of Intracoronary N-Acetylcysteine in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Sponsor: dr. Ahmad Yasa, Sp.JP, Subsp.K.I.(K), M.Kes, FIHA, FasCC, FA. Phase: PHASE2. Conditions: STEMI - ST Elevation Myocardial Infarction (MI), Primary PCI - STEMI

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07548931: Cold Plasma and Early Microbial Colonization of Healing Abutments

    Sponsor: Kahramanmaras Sutcu Imam University. Phase: NA. Conditions: Tooth Loss

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07370402: The Analgesic Efficacy and Safety of Flurbiprofen Patch in Patients With Herpes Zoster

    Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07456553: Impacted Tooth With Immediate Implant Placement

    Sponsor: University of Bari Aldo Moro. Phase: NA. Conditions: Impacted Tooth

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07400653: A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Obesity, Overweight and/or Obesity, Overweight, Diabetes, Type 2, Type 2 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07057037: Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

    Sponsor: Inventera Inc.. Phase: PHASE3. Conditions: Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis, Rotator Cuff Tendonitis, Articular Cartilage Injury, Glenohumeral Ligament, Long Head Biceps Tendon Tear, Adhesive Capsulitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06166537: GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

    Sponsor: Imperial College London. Phase: NA. Conditions: Venous Thromboembolism, Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03816345: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Autoimmune Disease, Crohn Disease, Dermatomyositis, Hematopoietic and Lymphoid Cell Neoplasm, Inflammatory Bowel Disease, Malignant Solid Neoplasm, Multiple Sclerosis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Systemic Scleroderma, Ulcerative Colitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06563895: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    Sponsor: Eidos Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07320677: Finding Heart Failure in Those Prescribed Loop Diuretics in Primary Care in Jersey

    Sponsor: Government of Jersey. Phase: NA. Conditions: Heart Failure, Diuretics

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07523412: Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

    Sponsor: Ain Shams University. Phase: PHASE4. Conditions: Peri-implant Bone and Soft Tissues

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07323381: Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM

    Sponsor: Bin Lu. Phase: PHASE4. Conditions: Diabetes Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07533981: ¹²⁹Xe(XENON) MRI Program

    Sponsor: Alexei Ouriadov. Phase: NA. Conditions: Healthy Volunteers - Male and Female

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02598219: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

    Sponsor: Centre Oscar Lambret. Phase: PHASE3. Conditions: Non Endometrioid Carcinoma, Endometrioid Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04702581: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery

    Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05036681: A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Metastatic Cancer, Endometrium Cancer, Endometrial Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07475819: Posture Exercises and Ergonomics Education

    Sponsor: Bahçeşehir University. Phase: NA. Conditions: Work Related Musculoskeletal Disorders, Ergonomic Risk Exposure, Postural Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03358719: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

    Sponsor: Roswell Park Cancer Institute. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome, Refractory Anemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05966519: ROSA Knee Intraoperative Planning Flexibility Study

    Sponsor: Zimmer Biomet. Phase: . Conditions: Osteo Arthritis Knee, Rheumatoid Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04648930: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Allergic Rhinitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05185128: Neural Basis of Social Cognition Deficits

    Sponsor: Loma Linda University. Phase: NA. Conditions: Autism Spectrum Disorder, Psychosis, Social Communication

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03439865: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

    Sponsor: University of Alabama at Birmingham. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis (Diagnosis)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07389967: Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer, Breast Cancer Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07487467: Autologous SVF Therapy for Type 2 Diabetes

    Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06630000: Focused Acceptance and Commitment Therapy (FACT)

    Sponsor: Children's Mercy Hospital Kansas City. Phase: NA. Conditions: Pediatric Feeding Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07436507: Effects of a Combined Home-Based Exercise Program on Dual-Task Gait Performance, EEG Markers of Cognitive-Motor Control, and Pain in Females With Primary Dysmenorrhea: A Randomized Controlled Trial

    Sponsor: University of Sharjah. Phase: NA. Conditions: Dysmenorrhea Primary

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07395492: App-Based Education and Low-Residue Diet for Colonoscopy Preparation

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Bowel Preparation Solution

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07018336: Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients

    Sponsor: Istinye University. Phase: NA. Conditions: Hemiplegia, Stroke, Upper Extremity Dysfunction

    full page →ctgov ↗
    ›TEMPORARILY_NOT_AVAILABLEphase readoutNCT06383611: Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

    Sponsor: Osteal Therapeutics, Inc.. Phase: . Conditions: Prosthetic-joint Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03838536: Synergistic Activity of Human Milk Nutrients and Infant Cognition

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Breastfeeding, Exclusive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01048736: Investigating Fitness Interventions in the Elderly (INFINITE)

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Obesity, Older Adults, Sedentary

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07029711: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Severe Alopecia Areata

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07447271: Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block

    Sponsor: Pusan National University Yangsan Hospital. Phase: NA. Conditions: Cervical Radiculopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01898494: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Oropharynx

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394166: Balancing Emotions and Electronics: A Pilot Intervention for Preschoolers

    Sponsor: Boston Children's Hospital. Phase: NA. Conditions: Screen Media Use

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07491666: Effects of Neuromuscular Exercises on Motor Skills in Girls

    Sponsor: University of Novi Sad. Phase: NA. Conditions: Motor Skills, Locomotor Activity, Objective Control Skills

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07173166: Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

    Sponsor: Instituto de Investigacion Sanitaria INCLIVA. Phase: NA. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00024622: PET Scanning in Parkinson s Disease

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Schizophrenia, Parkinson's Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07486102: A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy, Hepatic Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06853002: Deep Breathing Exercises and Incentive Spirometry After Rib Fracture

    Sponsor: Samsun University. Phase: NA. Conditions: Rib Fractures, Oxygenation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495137: The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection

    Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Endoscopic Submucosal Dissection, Endoscopic Submucosal Dissection (ESD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07145437: Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

    Sponsor: Clinique Sainte Clotilde. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05729945: Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study

    Sponsor: University of New Mexico. Phase: NA. Conditions: Child Development, Child Behavior, Child Abuse, Child Neglect, Parenting, Delinquency, Criminal Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05746039: Feasibility of Semaglutide in Advanced Lung Disease

    Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Sarcoidosis, Pulmonary, Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05756777: A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia (AML)

    full page →ctgov ↗
    ← prev
    page 61 of 159
    next →